Lucentis

Lucentis ATC Classification

ranibizumab

Manufacturer:

Novartis Pharma Stein

Distributor:

Novartis Healthcare

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

ATC Classification

S01LA04 - ranibizumab ; Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Sign up for Free to Continue Reading

Continue with Google

Sign up with email

Already a member? Sign in